AEON.WS
AEON Biopharma, Inc. Warrants, each whole warrant exercisable to purchase one share of Class A Common Stock at an exercise price of $11.50 per share
AEON.WS
AEON.WS
Delisted
AEON.WS was delisted on the 26th of April, 2024.
52 hedge funds and large institutions have $6.9M invested in AEON Biopharma, Inc. Warrants, each whole warrant exercisable to purchase one share of Class A Common Stock at an exercise price of $11.50 per share in 2022 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 6 increasing their positions, 5 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
52
Holders Change
+2
Holders Change %
+4%
% of All Funds
0.88%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
6
Reduced
5
Closed
4
Calls
$1M
Puts
–
Net Calls
+$1M
Net Calls Change
-$38K
Top Buyers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
PMAM
51
Picton Mahoney Asset Management
Toronto,
Ontario, Canada
| – | -$36K | -116,666 | Closed |
|
|
SCC
52
Spring Creek Capital
Wichita,
Kansas
| – | -$26K | -83,333 | Closed |
|
|
CC
53
Covalis Capital
London,
United Kingdom
| – | -$180K | -41,665 | Closed |
|
54
JPMorgan Chase & Co
New York
| – | -$4K | – | – |
|